These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 476055)

  • 21. Kinetic characteristics and binding process of substrate analogs to the adenosine deaminase in the marine mussel, Mytilus edulis.
    Ogawa T; Aikawa Y; Aikawa T
    Comp Biochem Physiol B; 1987; 88(1):91-100. PubMed ID: 3677618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine to acyclovir as catalyzed by adenosine deaminase.
    Spector T; Jones TE; Beacham LM
    Biochem Pharmacol; 1983 Sep; 32(17):2505-9. PubMed ID: 6351865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.
    Schrader WP; Pollara B; Meuwissen HJ
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):446-50. PubMed ID: 24216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinity difference of adenosine deaminases for the purine riboside-epoxyactivated Sepharose 6B column.
    Ogawa T; Aikawa Y; Aikawa T
    Comp Biochem Physiol B; 1987; 88(2):491-5. PubMed ID: 3501359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine deaminase: solvent isotope and pH effects on the binding of transition-state and ground-state analogue inhibitors.
    Kurz LC; Frieden C
    Biochemistry; 1983 Jan; 22(2):382-9. PubMed ID: 6824635
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of substituent ribose on transition state affinity in reactions catalyzed by adenosine deaminase.
    Wolfenden R; Wentworth DF; Mitchell GN
    Biochemistry; 1977 Nov; 16(23):5071-7. PubMed ID: 562185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine aminohydrolase activity in the regenerating rat liver.
    Sheid B
    Arch Biochem Biophys; 1985 Apr; 238(1):259-62. PubMed ID: 3985621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase.
    Plunkett W; Alexander L; Chubb S; Loo TL
    Cancer Res; 1979 Sep; 39(9):3655-60. PubMed ID: 476690
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of lymphoid cell growth by adenine ribonucleotide accumulation. The role of phosphoribosylpyrophosphate-depletion induced pyrimidine starvation.
    van der Kraan PM; van Zandvoort PM; De Abreu RA; van Baal JM; Bakkeren JA
    Biochim Biophys Acta; 1987 Feb; 927(2):213-21. PubMed ID: 2434139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
    Lum CT; Sutherland DE; Foker JE; Najarian JS
    Surg Forum; 1977; 28():320-2. PubMed ID: 364724
    [No Abstract]   [Full Text] [Related]  

  • 31. Dextran-linked purine nucleosides as substrates and inhibitors of adenosine deaminase.
    Rosemeyer H; Körnig E; Seela F
    Eur J Biochem; 1982 Sep; 127(1):185-91. PubMed ID: 6183116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of adenosine deaminase in some experimental animal tumours and the possible therapeutic effect of the ADA inhibitor 2-deoxy-coformycin.
    Hall JG; Gyure L; Peppard J; Orlans E
    Br J Cancer; 1979 Nov; 40(5):750-4. PubMed ID: 508578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
    Plunkett W; Cohen SS
    Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major enhancement of the affinity of an enzyme for a transition-state analog by a single hydroxyl group.
    Kati WM; Wolfenden R
    Science; 1989 Mar; 243(4898):1591-3. PubMed ID: 2928795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tight-binding inhibitors--III. A new approach for the determination of competition between tight-binding inhibitors and substrates--inhibition of adenosine deaminase by coformycin.
    Cha S
    Biochem Pharmacol; 1976 Dec; 25(24):2695-702. PubMed ID: 1008893
    [No Abstract]   [Full Text] [Related]  

  • 36. Transition-state stabilization by adenosine deaminase: 1,6-addition of water to purine ribonucleoside, the enzyme's affinity for 6-hydroxy-1,6-dihydropurine ribonucleoside, and the effective concentration of substrate water at the active site.
    Jones W; Kurz LC; Wolfenden R
    Biochemistry; 1989 Feb; 28(3):1242-7. PubMed ID: 2713361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine deaminase from Saccharomyces cerevisiae: purification and characterization.
    Marmocchi F; Lupidi G; Venardi G; Riva F
    Biochem Int; 1987 Mar; 14(3):569-80. PubMed ID: 3297063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Structure of periodated ribonucleosides and ribonucleotides].
    Hansske F; Cramer F
    Carbohydr Res; 1977 Mar; 54(1):75-84. PubMed ID: 193643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme variants in normal and neoplastic intestinal mucosa.
    Trotta PP; Balis ME
    Cancer; 1977 Nov; 40(5 Suppl):2592-9. PubMed ID: 922701
    [No Abstract]   [Full Text] [Related]  

  • 40. Trazodone, a nontricyclic antidepressant, is an inhibitor of adenosine deaminase.
    Sheid B
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):149-52. PubMed ID: 3983468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.